D
Capricor Therapeutics, Inc. CAPR
$29.96 $23.60371.07% NASDAQ
Recommendation
Prev Close
$6.36
Volume
50,574
Avg Vol (90D)
1,623,200
Market Cap
$290.77M
Dividend & Yield
--
52-Week Range
$4.30 - $20.75
P/E (TTM)
--
EPS (TTM)
-$1.80
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Capricor Therapeutics (CAPR) Is Up 477.3% After HOPE-3 Phase 3 Win for Deramiocel - Has The Bull Case Changed?
12/4/2025 - Simply Wall St
Top Medical Stocks To Research - December 3rd
12/3/2025 - MarketBeat
'Pharma Bro' Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win
12/3/2025 - Stocktwits News Feed
Capricor Therapeutics Stock Skyrockets Over 340% On Positive Phase 3 HOPE-3 Trial Results
12/3/2025 - RTT News - Momentum Stocks
Alliance Global Partners Remains a Buy on Capricor Therapeutics (CAPR)
12/3/2025 - TipRanks Financial Blog
Capricor Therapeutics price target raised by $32 at Alliance Global, here's why
12/3/2025 - The Fly
Capricor Therapeutics: Shares Soaring After DMD Study Win - Ball Now In FDA's Court
12/3/2025 - SeekingAlpha
Wednesday Sector Leaders: Biotechnology, Trucking Stocks
12/3/2025 - Nasdaq News: Markets
Video: Wednesday Sector Leaders: Biotechnology, Trucking Stocks
12/3/2025 - Market News Video
Capricor Therapeutics price target raised to $60 from $24 at H.C. Wainwright
12/3/2025 - TipRanks Financial Blog
Capricor Therapeutics price target raised by $36 at H.C. Wainwright, here's why
12/3/2025 - The Fly
Here's Why Capricor Therapeutics Stock (CAPR) Took Off Today
12/3/2025 - TipRanks Financial Blog
Wall Street drifts near its all-time high as Marvell Technology jumps and Macy's sinks
12/3/2025 - Orange County Register: Business
Why Did Capricor Therapeutics Stock Skyrocket Today?
12/3/2025 - Stocktwits News Feed
Capricor Therapeutics Reports Positive HOPE-3 Trial Results
12/3/2025 - TipRanks Financial Blog
Capricor Therapeutics trading resumes
12/3/2025 - TipRanks Financial Blog
Capricor Therapeutics trading resumes
12/3/2025 - The Fly
Capricor Therapeutics trading halted, volatility trading pause
12/3/2025 - TipRanks Financial Blog
Capricor Therapeutics trading halted, volatility trading pause
12/3/2025 - The Fly
Capricor Therapeutics Duchenne Treatment Shows Strong Heart And Muscle Results In Trial
12/3/2025 - Benzinga
Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of ...
12/3/2025 - GuruFocus
Capricor Therapeutics says Phase 3 HOPE-3 study met primary endpoint
12/3/2025 - The Fly
Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
12/3/2025 - Globe Newswire
capricor sets 2nd approval attempt duchenne cell therapy phase 3 win
12/3/2025 - FierceBiotech.com - Biotech
Capricor Therapeutics (CAPR, $6.65) entered Uptrend as Momentum indicator ascends above 0 level on Dec 01, 2025
12/2/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$11.13M
EBITDA (TTM)
-$84.92M
EBIT (TTM)
-$86.68M
Net Income (TTM)
-$81.99M
Balance Sheet
Total Assets (Q)
$126.44M
Total Debt (Q)
$14.54M
Total Liabilities (Q)
$42.57M
Book Value Per Share (Q)
$1.83
Cash Flow
Cash from Operations (TTM)
-$61.04M
Cash from Investing (TTM)
-$68.99M
Cash from Financing (TTM)
$81.16M
Net Change in Cash (TTM)
-$48.87M
Filings
Filing Date
Monday, November 10, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
0.91
7-Day Total Return
421.04%
30-Day Total Return
370.33%
60-Day Total Return
362.35%
90-Day Total Return
341.24%
Year to Date Total Return
100.27%
1-Year Total Return
81.47%
2-Year Total Return
845.11%
3-Year Total Return
616.75%
5-Year Total Return
621.93%
52-week Low
Nov 25, 2025 - $4.30
52-week High
Dec 03, 2024 - $20.75
Valuation
Market Cap
$290.77M - Micro Cap
Enterprise Value
$206.75M
Price/Sales (TTM)
26.13
Price/Book (Q)
3.47
Dividends and Shares
Shares Outstanding
45.72
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.capricor.com
Phone Number
858 727 1755
Address
10865 Road to the Cure
San Diego, CA 92121
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed